FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Nubratori Inc. | 028707055 | 71300-6646 | 71300-6646-9 | Naltrexone Hydrochloride | 1.5 mg | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6646 | 71300-6646-3 | Naltrexone Hydrochloride | 1.5 mg | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6610 | 71300-6610-9 | Naltrexone Hydrochloride | 4.5 mg | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6647 | 71300-6647-9 | Naltrexone Hydrochloride | 4.5 mg | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6600 | 71300-6600-9 | Naltrexone Hydrochloride | 1.5 mg | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6635 | 71300-6635-2 | Baclofen | 20 mg/1 g | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6638 | 71300-6638-2 | Baclofen | 50 mg/1 g | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6631 | 71300-6631-1 | Dexamethasone Sodium Phosphate | 4 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6564 | 71300-6564-1 | Dexamethasone Sodium Phosphate | 4 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6573 | 71300-6573-1 | Diclofenac Sodium | 16 mg/1 g | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6632 | 71300-6632-1 | Diclofenac Sodium | 16 mg/1 g | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6624 | 71300-6624-2 | Epinephrine | .2 mg/.2 mL | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6704 | 71300-6704-3 | Acyclovir; Triamcinolone Acetonide; Dyclonine Hydrochloride | 367 mg/1 g; 167 mg/1 g; 33.3 mg/1 g | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6440 | 71300-6440-2 | Gabapentin | 100 mg/1 g | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6442 | 71300-6442-2 | Ketoprofen | 100 mg/1 g | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6591 | 71300-6591-1 | Lidocaine Hydrochloride; Bupivacaine Hydrochloride | 10 mg/1 mL; 3.75 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6622 | 71300-6622-5 | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 4 mg/1 mL; 2 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| OLYMPIA PHARMACY | 017674368 | Ondansetron Hydrochloride | 1 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Ornithine; Lysine Hydrochloride; Arginine Hydrochloride; Citrulline | 50 mg/1 mL; 40.02 mg/1 mL; 100 mg/1 mL; 50 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 3 mg/1 mL; .2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 3 mg/1 mL; .2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2 mg/1 mL; .02 mg/1 mL; .2 mg/1 mL; 20 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2 mg/1 mL; .02 mg/1 mL; .2 mg/1 mL; 20 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .03 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .03 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .3 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .3 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1.5 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1.5 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .01 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .29 mg/1 mL; .0029 mg/1 mL; 8 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .29 mg/1 mL; .0029 mg/1 mL; 8 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .1 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .1 mg/1 mL; 30 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| OLYMPIA PHARMACY | 017674368 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | .02 mg/1 mL; 1.8 mg/1 mL; .2 mg/1 mL; .018 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 |